Guru Ownership Trend
Guru Analysis for Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $253.59 M.
Top institutional holders include Catherine Wood and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bearish. This is evidenced by a $61.69 M net outflow during the quarter.
Recent activity highlights Stanley Druckenmiller who opened a new position. Conversely, Catherine Wood reduced exposure by 15.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for Beam Therapeutics Inc. (BEAM)
Major holders include Catherine Wood ($351.26 M), Renaissance Technologies (RenTech) ($15.27 M), Stanley Druckenmiller ($5.27 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 10.92 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $61.69 M, with 4 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited BEAM. The total reported sell value was $67.53 M.
Yes, 2 managers opened new positions in BEAM, and 2 increased their existing holdings. The total reported buy value was $5.84 M.
